PATENT CLAIM ANALYSIS

Application Number: 16176958
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "185000"]

Abstract:
The present disclosure relates to methods of treating a range of diseases or conditions. The methods involve administration of a superoxide dismutase mimetic.

Claim (Index 42):
A medicament for treating a human patient for tissue damage resulting from the administration of radiation therapy or chemotherapy to the patient, wherein the medicament is characterized by parenterally administering to the patient at least 75 mg of a superoxide dismutase mimetic within a period of 60 minutes, wherein the superoxide dismutase mimetic corresponds to Formula (GC4419): wherein X and Y are independently neutral or negatively-charged ligands.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13625617', '14837831', '12993140', '15751495', '15841586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.783538442820375
- 35 USC 102 Novelty (BERT): 0.5549440784197304
- Combined Prediction Score: 0.7606790063803105
- Mean Citation Score: 295.379324
- Max Citation Score: 425.81418
- Similarity Product: 339.8321933437371

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test